Surgery Partners, Inc. (NASDAQ:SGRY) – Stock analysts at KeyCorp lowered their Q3 2017 earnings per share (EPS) estimates for shares of Surgery Partners in a research note issued to investors on Tuesday. KeyCorp analyst J. Gurda now expects that the company will post earnings per share of $0.03 for the quarter, down from their prior estimate of $0.21. KeyCorp also issued estimates for Surgery Partners’ Q4 2017 earnings at $0.37 EPS, FY2017 earnings at $0.43 EPS, FY2018 earnings at $0.75 EPS and FY2019 earnings at $1.22 EPS.
SGRY has been the subject of a number of other reports. BidaskClub downgraded shares of Surgery Partners from a “sell” rating to a “strong sell” rating in a report on Saturday, August 5th. Zacks Investment Research downgraded shares of Surgery Partners from a “hold” rating to a “sell” rating in a report on Wednesday, May 10th. Stifel Nicolaus downgraded shares of Surgery Partners from a “hold” rating to a “sell” rating and dropped their price objective for the stock from $21.00 to $17.00 in a report on Wednesday. Citigroup Inc. dropped their price objective on shares of Surgery Partners from $28.00 to $17.00 and set a “buy” rating for the company in a report on Friday. Finally, Raymond James Financial, Inc. reaffirmed a “market perform” rating on shares of Surgery Partners in a report on Wednesday. Three equities research analysts have rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the stock. Surgery Partners presently has an average rating of “Hold” and an average price target of $20.67.
Surgery Partners (NASDAQ:SGRY) opened at 11.10 on Friday. Surgery Partners has a 12 month low of $9.20 and a 12 month high of $24.05. The firm’s 50-day moving average price is $20.32 and its 200-day moving average price is $20.21. The firm has a market cap of $541.80 million, a P/E ratio of 73.03 and a beta of 1.71.
Hedge funds have recently bought and sold shares of the company. AMI Asset Management Corp increased its stake in Surgery Partners by 26.4% in the second quarter. AMI Asset Management Corp now owns 547,162 shares of the company’s stock worth $12,448,000 after buying an additional 114,288 shares in the last quarter. State Street Corp boosted its position in shares of Surgery Partners by 8.0% in the fourth quarter. State Street Corp now owns 268,021 shares of the company’s stock worth $4,251,000 after buying an additional 19,842 shares during the last quarter. Wells Fargo & Company MN boosted its position in shares of Surgery Partners by 26.3% in the first quarter. Wells Fargo & Company MN now owns 397,454 shares of the company’s stock worth $7,750,000 after buying an additional 82,871 shares during the last quarter. Ameriprise Financial Inc. boosted its position in shares of Surgery Partners by 404.9% in the first quarter. Ameriprise Financial Inc. now owns 228,970 shares of the company’s stock worth $4,465,000 after buying an additional 183,620 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new position in shares of Surgery Partners during the first quarter worth approximately $244,000. 39.36% of the stock is owned by institutional investors.
About Surgery Partners
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.